A5060263108- Respiratory and Cough-Related Research
- Pediatric health and respiratory diseases
- Dysphagia Assessment and Management
- Cystic Fibrosis Research Advances
- Long-Term Effects of COVID-19
- Inflammasome and immune disorders
- Streptococcal Infections and Treatments
- Respiratory Support and Mechanisms
- Asthma and respiratory diseases
- Plant-based Medicinal Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Otolaryngology and Infectious Diseases
- Chronic Obstructive Pulmonary Disease (COPD) Research
- COVID-19 Clinical Research Studies
Guangzhou University of Chinese Medicine
2023-2025
Guangdong Provincial Hospital of Traditional Chinese Medicine
2023
Guangdong Academy of Medical Sciences
2022
Traditional Chinese medicine has been used for Coronavirus disease 2019 (COVID-19) as a therapeutic option. Lianhuaqingwen capsules (LHQW) are well-recognized their efficacy, while Kegan Liyan oral liquid (KGLY), widely influenza treatment, emerged promising candidate COVID-19 therapy. This trial aims to assess whether KGLY is non-inferior LHQW in treating mild COVID-19. A total of 127 participants (63 group and 64 group) were randomly allocated receive either therapy or 1:1 ratio. The...